Trial intelligence / Profile preview

Olanzapine vs Risperidone in Bipolar I Disorder

NCT00034580Phase 4Completed

Sponsor
Eli Lilly and Company
Start
Aug 2001
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of olanzapine in bipolar I disorder, sponsored by Eli Lilly and Company. Started Aug 2001; status: completed.

02

Drugs

olanzapine
03

Conditions

bipolar I disorder

Beyond the preview

Go deeper on NCT00034580.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00034580.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call